BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11745003)

  • 41. Hyperglycemia and the pathobiology of diabetic complications.
    Aronson D
    Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein kinase C activation and the development of diabetic complications.
    Koya D; King GL
    Diabetes; 1998 Jun; 47(6):859-66. PubMed ID: 9604860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The missing link: a single unifying mechanism for diabetic complications.
    Nishikawa T; Edelstein D; Brownlee M
    Kidney Int Suppl; 2000 Sep; 77():S26-30. PubMed ID: 10997687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of hyperglycemia in the development of diabetic complications.
    Schleicher E; Nerlich A
    Horm Metab Res; 1996 Aug; 28(8):367-73. PubMed ID: 8886821
    [No Abstract]   [Full Text] [Related]  

  • 45. Biochemical and molecular mechanisms in the development of diabetic vascular complications.
    King GL; Kunisaki M; Nishio Y; Inoguchi T; Shiba T; Xia P
    Diabetes; 1996 Jul; 45 Suppl 3():S105-8. PubMed ID: 8674872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cellular and molecular mechanisms of diabetic complications.
    King GL; Brownlee M
    Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Protein kinase C activation and diabetic complications].
    Yamamoto-Honda R; Kadowaki T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():67-72. PubMed ID: 15999687
    [No Abstract]   [Full Text] [Related]  

  • 48. Igf-I signaling in response to hyperglycemia and the development of diabetic complications.
    Clemmons D; Maile L; Xi G; Shen X; Radhakrishnan Y
    Curr Diabetes Rev; 2011 Jul; 7(4):235-45. PubMed ID: 21707534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetics: mechanisms and implications for diabetic complications.
    Cooper ME; El-Osta A
    Circ Res; 2010 Dec; 107(12):1403-13. PubMed ID: 21148447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications.
    Lee TS; Saltsman KA; Ohashi H; King GL
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5141-5. PubMed ID: 2740348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications.
    Jubaidi FF; Zainalabidin S; Taib IS; Abdul Hamid Z; Mohamad Anuar NN; Jalil J; Mohd Nor NA; Budin SB
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetes: many leads to PKC (protein kinase C).
    Pfeiffer A
    Exp Clin Endocrinol Diabetes; 1996; 104(1):17-8. PubMed ID: 8750565
    [No Abstract]   [Full Text] [Related]  

  • 53. Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.
    Akhtar S; Yousif MH; Dhaunsi GS; Sarkhouh F; Chandrasekhar B; Attur S; Benter IF
    PLoS One; 2013; 8(6):e67813. PubMed ID: 23826343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Protein kinase C activation].
    Satoh S
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():53-9. PubMed ID: 21667468
    [No Abstract]   [Full Text] [Related]  

  • 55. Ca(2+) handling alterations and vascular dysfunction in diabetes.
    Fernández-Velasco M; Ruiz-Hurtado G; Gómez AM; Rueda A
    Cell Calcium; 2014 Nov; 56(5):397-407. PubMed ID: 25218935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular and molecular effects of hyperglycemia on ion channels in vascular smooth muscle.
    Nieves-Cintrón M; Flores-Tamez VA; Le T; Baudel MM; Navedo MF
    Cell Mol Life Sci; 2021 Jan; 78(1):31-61. PubMed ID: 32594191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome.
    Inoguchi T; Nawata H
    Curr Drug Targets; 2005 Jun; 6(4):495-501. PubMed ID: 16026268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration.
    Yasunari K; Kohno M; Kano H; Yokokawa K; Horio T; Yoshikawa J
    Hypertension; 1996 Aug; 28(2):159-68. PubMed ID: 8707376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pathobiology of diabetes mellitus: implications for surgeons.
    Kamal K; Powell RJ; Sumpio BE
    J Am Coll Surg; 1996 Sep; 183(3):271-89. PubMed ID: 8784324
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of lipoxygenase in the regulation of glucose transport in aortic vascular cells.
    Sasson S; Davarashvili A; Reich R
    Adv Exp Med Biol; 1999; 469():377-83. PubMed ID: 10667356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.